Epinephrine levels decrease in responders after electroconvulsive therapy

J Neural Transm (Vienna). 2021 Dec;128(12):1917-1921. doi: 10.1007/s00702-021-02420-1. Epub 2021 Sep 23.

Abstract

We examined potential changes in catecholamine plasma levels and cortisol serum levels in 29 patients with treatment-resistant Major Depressive Disorder (MDD) during a course of electroconvulsive therapy (ECT). Blood samples were taken at three different time points: directly before (T1) and 15 min after (T2) the first ECT, and directly before the last one (T3). Patients responding to ECT had a significant decrease of the intraindividual epinephrine plasma level when both first time points (Δ T1-T2) were compared (χ2 (1) = 10.05, p = 0.002). This finding encourages further investigation in the understanding of the catecholamine-metabolism including its release and uptake in patients with treatment-resistant MDD receiving ECT.

Keywords: Catecholamine; Cortisol; Electroconvulsive therapy (ECT); Major Depressive Disorder (MDD); Treatment-resistant depression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Depressive Disorder, Major* / therapy
  • Depressive Disorder, Treatment-Resistant* / therapy
  • Electroconvulsive Therapy*
  • Epinephrine
  • Humans
  • Treatment Outcome

Substances

  • Epinephrine